Terry Katz, CEO and co-founder of ForgeStop Technology Corporation, explains how the company’s product is worth the investment by protecting products and patients.
News|Articles|August 20, 2015
Elizabeth Scheu & Kniss Partners with Carlisle Precision Machining to Supply Capsule-Filling Machine Replacement Parts
Author(s)Pharmaceutical Technology Editors
Elizabeth Scheu & Kniss will supply replacement parts for Bosch capsule filling machines.
Elizabeth Scheu & Kniss (Louisville, KY) and Carlisle Precision Machining (Nampa, ID) announced a partnership on Aug. 1, 2015 to offer high precision replacement parts for Bosch capsule filling machines. The partnership will leverage the proven experience of Carlisle Precision to reliably engineer popular replacement parts for a wide range of Bosch and derivative capsule-filling machines as an economic alternative to original equipment manufacturer (OEM) parts, along with the global reach and high standards for customer service by Scheu & Kniss.
“We are pleased to collaborate with Carlisle Precision to extend our product offering across the solid dose manufacturing department. Our extensive offering of rotary tablet press parts has proven time and again as a reliable and cost effective alternative to OEM parts. We are equally confident in the Carlisle line of capsule filling parts,” said David Risinger, general manager of Elizabeth Scheu & Kniss, in a press release.
Source:
Related to this article
Terry Katz, CEO and co-founder of ForgeStop Technology Corporation, explains how its connected technology can enhance anticounterfeiting and how data are handled within the product.
Celtic Renewables won the CPHI Award for Sustainable Pharma Excellence for its green chemicals used in pharmaceutical manufacturing. Bettina Brierley, chief commercial officer, talks about the adoption, capacity, and pricing of biosolvents.
Terry Katz, CEO and cofounder of ForgeStop Technology Corporation, explains the company’s CPHI Award-winning connected product technology and how it helps to combat drug counterfeiting.
Bettina Brierley, chief commercial officer at Celtic Renewables, discusses commercialization of biosolvents for pharmaceutical manufacturing.
Coverage from AAPS PharmSci 360 and CPHI Milan featured discussion about impurities, devices, and supply resilience. This week also included topics such as AI accountability, oral peptides, and new licensing deals.
CDMOs, OEMs, and Used Equipment Resellers are Joining Forces to Onshore Pharmaceutical Manufacturing
Onshoring pharmaceutical manufacturing can be made more practical by collaborating with CDMOs that have gray space, supported by strong relationships with used equipment dealers and OEMs.
USP data show fewer US drug shortages but longer ones, averaging 5+ years. Drug shortages are an incentive problem, not a manufacturing mystery.
Trending on Pharmaceutical Technology
1
Signs Point to FDA Shelving Priority Voucher Pilot, Stalling Fast-Track Drug Reviews
2
Our Biggest Takeaways From AAPS PharmSci 360
3
France Remains One of Europe’s Leading Biotech Funding Hubs
4
PharmTech AI Pulse Check: Who's Accountable When a Vendor's AI Model Changes?
5